Unknown

Dataset Information

0

Advances in the systemic treatment of triple-negative breast cancer.


ABSTRACT: Triple-negative breast cancer constitutes a heterogeneous group of malignancies that are often aggressive and associated with a poor prognosis. Molecular characterization, while not a standard of care, can further subtype triple-negative breast cancer and provide insight into prognostication and behaviour. Optimal chemotherapy regimens have yet to be established; however, there have been advances in the systemic treatment of triple-negative breast cancer in the neoadjuvant, adjuvant, and metastatic settings. In this review, we discuss evidence for the potential benefit of neoadjuvant platinum-based chemotherapy, adjuvant combination chemotherapy with weekly paclitaxel, and BRCA mutation-directed therapy in the metastatic setting. The role for adjuvant capecitabine in patients who do not achieve a pathologic complete response with neoadjuvant chemotherapy is reviewed. Future directions and data concerning novel targeted agents are reviewed, including the most recent data on parp [poly (adp-ribose) polymerase] inhibitors, antiandrogen agents, and immunotherapy.

SUBMITTER: Lebert JM 

PROVIDER: S-EPMC6001760 | biostudies-literature | 2018 Jun

REPOSITORIES: biostudies-literature

altmetric image

Publications

Advances in the systemic treatment of triple-negative breast cancer.

Lebert J M JM   Lester R R   Powell E E   Seal M M   McCarthy J J  

Current oncology (Toronto, Ont.) 20180613 Suppl 1


Triple-negative breast cancer constitutes a heterogeneous group of malignancies that are often aggressive and associated with a poor prognosis. Molecular characterization, while not a standard of care, can further subtype triple-negative breast cancer and provide insight into prognostication and behaviour. Optimal chemotherapy regimens have yet to be established; however, there have been advances in the systemic treatment of triple-negative breast cancer in the neoadjuvant, adjuvant, and metasta  ...[more]

Similar Datasets

| S-EPMC6681627 | biostudies-literature
| S-EPMC6819447 | biostudies-literature
| S-EPMC10252475 | biostudies-literature
| S-EPMC7383279 | biostudies-literature
| S-EPMC7871289 | biostudies-literature
| S-EPMC4807882 | biostudies-literature
| S-EPMC9434975 | biostudies-literature
| S-EPMC6507064 | biostudies-literature
| S-EPMC5465752 | biostudies-literature
| S-EPMC7968109 | biostudies-literature